Triglio (Targepeutics)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug NameTriglio (Targepeutics)
Drug Alias NameIL-13 based cytotoxin (Targepeutics)
ClassificationBiologics > Protein drugs > Recombinant polypeptideBiologics > Protein drugs > Toxin
Mechanisms of ActionInterleukin 13 receptor agonists
TargetsInterleukin 13 receptor
Therapy Area/IndicationsBrain Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesTargepeutics
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesTargepeutics
Active IndicationsN/A
Inactive IndicationsBrain Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A